Search tool

Cover of the report on Review of mathematical modelling studies of opioid agonist treatment and needle and syringe programmes for preventing hepatitis C transmission

Technical reports

Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Review of mathematical modelling studies of opioid agonist treatment and needle and syringe programmes for preventing hepatitis C transmission

This report describes the methods and findings of a systematic review of mathematical modelling studies of the population-level impact of opioid agonist treatment (OAT) and needle and syringe programmes (NSPs) on hepatitis...

Cover of the report on Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour

Technical reports

Evidence for the effectiveness of interventions to prevent infections among people who inject drugs: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour

This report describes the methods and findings of systematic reviews of the literature undertaken to update the European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and...

Ad hoc publication

EMCDDA Environmental policy 2023

This environmental policy statement provides a unifying vision that will guide the actions of the EMCDDA's employees, management, shareholders, customers and suppliers. It clearly outlines, where the EMCDDA stands on environmental matters...

Joint publications

EU Drug Market: Amphetamine — In-depth analysis

EU Drug Market: Amphetamine describes the European amphetamine market from production and trafficking, to distribution and use. It details the processes, materials and actors involved at different stages and levels of the...

Joint publications

EU Drug Market: Amphetamine — Actions to address current threats and increase preparedness

This page presents the strategic priority areas emerging from the analysis of the EU amphetamine market that will address the health and security problems associated with the amphetamine market. Broadly, they involve...

Joint publications

EU Drug Market: Amphetamine — Effects, risks and harms of use

This page presents an overview of the effects, risks and harms associated with amphetamine use, providing data from syringe residue analysis and treatment-seeking for amphetamine use, as well as information on acute...

Joint publications

EU Drug Market: Amphetamine — Retail markets

This page presents an overview of the retail market for amphetamine in Europe, providing an analysis of the market size and the quantities of amphetamine seized in the EU. In addition, data...

Joint publications

EU Drug Market: Amphetamine — Prices and purities

This page presents an overview of issues related to price and purity in the amphetamine market in Europe, providing detailed analysis, based on data available, on price and purity in individual countries...

Joint publications

EU Drug Market: Amphetamine — Criminal networks

This page presents an overview of criminal networks in the amphetamine market in Europe, providing information on cooperation between networks, the provision of ‘crime-as-a-service’, and key enablers of amphetamine trafficking including legal...

Joint publications

EU Drug Market: Amphetamine — Trafficking and supply

This page presents an overview of amphetamine trafficking in Europe, providing information on seizures, trafficking routes and methods, Europe’s role in the captagon trade and online distribution.